Kristen Marie Carr-O'Dwyer

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

U-M Rogel Cancer Center(Current)

Sarah Cannon

Moffitt Cancer Center

Vanderbilt University

Texas Oncology

Kristen Marie Carr-O'Dwyer is an author at U-M Rogel Cancer Center specializing in hematology, relapsed acute lymphoblastic leukemia, and cell therapy.

Publications per year

2018–2019

Publications

End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).

Bijal Shah, Michael Bishop, Olalekan O. Oluwole et al. · Journal of Clinical Oncology · 2019 · 38 citations

Medicine, Hematology, Oncology +17

Outcomes of patients (pts) treated with prior blinatumomab (Blin) in ZUMA-3: A study of KTE-C19, an anti-CD19 chimeric antigen receptor (CAR) t cell therapy, in adult pts with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).

Bijal Shah, Olalekan O. Oluwole, Maria R. Baer et al. · Journal of Clinical Oncology · 2018 · 12 citations

Life Sciences, Hematology, Oncology +16

1–2 of 2